+1 877 705 191424 / 7
HIPAA Compliant
ISO 27001 Certified

Status Unknown

Phase 1
Phase 2
Age: 18Years - 70Years
All Genders
ID05329636

Fecal Auto-transplantation for Enteric Microbial Rehabilitation Post 14 Day Antibiotics Therapy Against Helicobacter Pylori Infection

Led by Tel-Aviv Sourasky Medical Center · Updated on 2024-07-08

30

Participants Needed

1

Research Sites

52 weeks

Total Duration

AI-Summary

What this Trial Is About

Current guidelines mandate Helicobacter pylori (H. Pylori) eradication with 2-3 antibiotics for 14 days ,This may result in multiple side effects and in eradication of important bacterial species to human health, exposing humans to multiple disease conditions. Preservation of fecal microbiome prior to antibiotic therapy and auto-transplantation of the microbes post H. pylori eradication, will enable avoiding eradication of beneficial microbial populations and perhaps protect from consequent disease conditions.

CONDITIONS

Brief Title

Auto Fecal Microbial Transplant Post Helicobacter Pylori Antibiotic Therapy

Research Team

N

Nitsan Maharshak, MD

R

Rony Izhar, PHD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here